This compound is a this compound derivative. It is primarily used as a pharmaceutical intermediate in the manufacturing of kinase inhibitors for research and development purposes.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1220518-04-6
Tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
Pharmaceutical intermediate for kinase inhibitors
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
Pharmaceutical intermediate for kinase inhibitors
Acarbose Impurity E
Acarbose impurity reference standard
Acarbose EP Impurity B
Impurity standard for acarbose analysis
(2R,3R)-2-[(benzoyloxy)methyl]-4,4-difluoro-5-oxooxolan-3-yl benzoate
pharmaceutical intermediate
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
pharmaceutical intermediate for nucleoside analogs
2,4-dichloro-7-cyclopropylpyrrolo[2,3-d]pyrimidine
FWAVMANUFQKJFX-UHFFFAOYSA-N
C1CC1N2C=CC3=C2N=C(N=C3Cl)Cl
—